Literature DB >> 20395261

The prognostic importance of lung function in patients admitted with heart failure.

Kasper Karmark Iversen1, Jesper Kjaergaard, Dilek Akkan, Lars Kober, Christian Torp-Pedersen, Christian Hassager, Jorgen Vestbo, Erik Kjoller.   

Abstract

AIMS: The purpose of the present study was to determine the prognostic importance for all-cause mortality of lung function variables obtained by spirometry in an unselected group of patients admitted with heart failure (HF). METHODS AND
RESULTS: This was a prospective prognostic study performed as part of the EchoCardiography and Heart Outcome Study (ECHOS). This analysis included 532 patients admitted with a clinical diagnosis of HF. All patients underwent spirometry and echocardiography and the diagnosis of HF was made according to established criteria. Mean forced expiratory volume in 1 s (FEV(1)) was 65% of the predicted value [95% confidence interval (CI) 63-67%], mean forced vital capacity (FVC) was 71% of predicted (95% CI 69-72%), and FEV(1)/FVC was 0.72 (95% CI 0.71-0.73). FEV(1), FVC, and FEV(1)/FVC were all significant prognostic factors for all-cause mortality in univariate analyses. In a multivariate analysis, FEV(1) had independent prognostic value (hazard ratio 0.86 per 10% change, P < 0.001) after adjusting for demographic variables, known risk factors, ejection fraction, and self-reported chronic obstructive pulmonary disease.
CONCLUSION: Pulmonary function provides significant prognostic information for all-cause mortality in patients admitted with HF. Spirometry therefore seems to be worth considering for all patients admitted with HF in order to identify patients at high risk.

Entities:  

Mesh:

Year:  2010        PMID: 20395261     DOI: 10.1093/eurjhf/hfq050

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  32 in total

1.  Patient perception versus medical record entry of health-related conditions among patients with heart failure.

Authors:  Adnan S Malik; Grigorios Giamouzis; Vasiliki V Georgiopoulou; Lucy V Fike; Andreas P Kalogeropoulos; Catherine R Norton; Dan Sorescu; Sidra Azim; Sonjoy R Laskar; Andrew L Smith; Sandra B Dunbar; Javed Butler
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

Review 2.  Cardiac biomarkers: new tools for heart failure management.

Authors:  Navaid Iqbal; Bailey Wentworth; Rajiv Choudhary; Alejandro De La Parra Landa; Benjamin Kipper; Arrash Fard; Alan S Maisel
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

3.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

4.  Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study.

Authors:  Kimberly A Fisher; Mihaela S Stefan; Chad Darling; Darleen Lessard; Robert J Goldberg
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 5.  Obstructive Ventilatory Disorder in Heart Failure-Caused by the Heart or the Lung?

Authors:  Sergio Caravita; Jean-Luc Vachiéry
Journal:  Curr Heart Fail Rep       Date:  2016-12

Review 6.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors:  Filippos Triposkiadis; Randall C Starling; Harisios Boudoulas; Gregory Giamouzis; Javed Butler
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

7.  Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure.

Authors:  Brice Arnaudis; Olivier Lairez; Roger Escamilla; Audrey Fouilloux; Pauline Fournier; Benoit Monteil; Frédéric Bouisset; Jean-François Arnal; Meyer Elbaz; Didier Carrié; Jérôme Roncalli; Atul Pathak; Michel Galinier
Journal:  Clin Res Cardiol       Date:  2012-04-09       Impact factor: 5.460

8.  Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure.

Authors:  Qiaojun Zeng; Shanping Jiang
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

9.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

Review 10.  Co-morbidities in heart failure.

Authors:  Vincent M van Deursen; Kevin Damman; Peter van der Meer; Peter J Wijkstra; Gert-Jan Luijckx; Andre van Beek; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.